Literature DB >> 11697823

Is there quality in clinical benefit?

C B Steer, G M Marx, P G Harper.   

Abstract

Mesh：

Year:  2001        PMID： 11697823     DOI： 10.1023/a:1012474308888

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

Review 1.  Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer?

Authors:  Lothar R Pilz; Christian Manegold; Gerald Schmid-Bindert
Journal:  Transl Lung Cancer Res       Date:  2012-03

2.  Clinical and outcome research in oncology. The need for integration.

Authors:  Giovanni Apolone
Journal:  Health Qual Life Outcomes       Date:  2003-04-03       Impact factor: 3.186

3.  Surrogate end points of quality of life assessment: have we really found what we are looking for?

Authors:  Davide Tassinari
Journal:  Health Qual Life Outcomes       Date:  2003-11-24       Impact factor: 3.186
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.